Skip to content

Study on Pathogenesis of Hypoxic Pulmonary Hypertension Based on Intestinal Microbes and Intervention by Tonifying Lung, Eliminating Phlegm and Removing Blood Stasis

Study on Pathogenesis of Hypoxic Pulmonary Hypertension Based on Intestinal Microbes and Intervention by Tonifying Lung, Eliminating Phlegm and Removing Blood Stasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052033
Enrollment
Unknown
Registered
2021-10-14
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary hypertension

Interventions

Chronic obstructive pulmonary disease and pulmonary hypertension group:No

Sponsors

The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-80 years, and the patient has related abilities such as autonomous activities; 2. According to the 2017 edition of Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease, diagnosed as chronic obstructive pulmonary disease; 3. Meet the diagnostic criteria of pulmonary hypertension: use color Doppler echocardiography of the heart to estimate the pulmonary artery pressure through the tricuspid regurgitation area, exclude the stenosis of the right ventricular outflow system, pulmonary artery systolic pressure = right ventricular systolic pressure, (pulmonary artery systolic pressure >= 40 mmHg); 4. Meet the diagnostic criteria of deficiency of lung qi and mutual resistance of phlegm and blood stasis in Traditional Chinese Medicine; 5.The baseline of 6MWD is >= 100 m and < 450 m.

Exclusion criteria

Exclusion criteria: 1. Important organs have serious primary diseases; 2. For those who have used targeted drug therapy and stopped or changed the targeted drug for less than 3 months; 3. Those with infectious diseases such as hepatitis A, hepatitis B, AIDS, tuberculosis, or active connective tissue diseases; severe infections, especially those with lung infections; 4. Patients with liver cirrhosis or portal hypertension caused by liver cirrhosis; 5. Severe bleeding or bleeding tendency; 6. Cardiac Doppler ultrasound indicates that the left ventricular ejection fraction is less than 45%; 7. Have history of bowel surgery; 8. Take antibiotics, probiotics, prebiotics, non-steroidal anti-inflammatory drugs (NSAIDs), opioids, Traditional Chinese Medicines (TCM), proton pump inhibitors (PPI) or histamine receptor antagonists within one month before sample collection.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;Liver function;Routine blood examination;General physical examination items;Analysis of Traditional Chinese Medicine syndrome types;

Countries

China

Contacts

Public ContactWang Feiying

Hu'nan University of Traditional Chinese Medicine

378931484@qq.com+86 18229901943

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026